Cargando…
Successful Regulatory T Cell-Based Therapy Relies on Inhibition of T Cell Effector Function and Enrichment of FOXP3+ Cells in a Humanized Mouse Model of Skin Inflammation
BACKGROUND: Recent clinical trials using regulatory T cells (Treg) support the therapeutic potential of Treg-based therapy in transplantation and autoinflammatory diseases. Despite these clinical successes, the effect of Treg on inflamed tissues, as well as their impact on immune effector function i...
Autores principales: | Landman, S., de Oliveira, V. L., Peppelman, M., Fasse, E., van Rijssen, E., Bauland, S. C., van Erp, P., Joosten, I., Koenen, H. J. P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244960/ https://www.ncbi.nlm.nih.gov/pubmed/32509883 http://dx.doi.org/10.1155/2020/7680131 |
Ejemplares similares
-
Intradermal injection of low dose human regulatory T cells inhibits skin inflammation in a humanized mouse model
por: Landman, Sija, et al.
Publicado: (2018) -
DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4(+)CD25(high) FOXP3(+) Regulatory T Cells but Does Not Affect Their Suppressive Capacity
por: Landman, Sija, et al.
Publicado: (2018) -
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
por: Strohbuecker, Lisa, et al.
Publicado: (2019) -
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells
por: He, Xuehui, et al.
Publicado: (2016) -
Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells
por: He, Xuehui, et al.
Publicado: (2017)